Literature DB >> 21088504

Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short review.

Paolo Zanotti-Fregonara1, Isabelle Keller, Marie Calzada-Nocaudie, Adil Al-Nahhas, Jean-Yves Devaux, Gaia Grassetto, Maria Cristina Marzola, Domenico Rubello, Elif Hindié.   

Abstract

After thyroidectomy and 131I ablation for differentiated thyroid cancer (DTC), serum thyroglobulin (Tg) became a sensitive marker of residual disease. It is not uncommon to find patients at follow-up with persistent serum Tg levels and no other clinical or imaging evidence for the disease. The vast majority of these patients, most probably, have occult foci of disease, often in minute cervical lymph nodes. A review of the literature including papers published on PubMed/Medline until June 2010 was made. In this study we speculated that a minority of patients who had undergone surgery for differentiated thyroid cancer might have benign sources of Tg secretion at follow-up. These sources may be foci of radio-resistant ectopic thyroid tissue or a thyroid stimulating hormone-stimulated thymus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088504     DOI: 10.1097/MNM.0b013e328340e717

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  8 in total

1.  Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of the thyroid: an unusual cause of thyroglobulin-positive radioactive iodine-negative whole-body scans.

Authors:  Vahab Fatourechi; John C Morris; Thomas J Sebo
Journal:  Thyroid       Date:  2014-07-14       Impact factor: 6.568

2.  Accuracy of unstimulated Basal serum thyroglobulin levels in assessing the completeness of thyroidectomy.

Authors:  Emin Gurleyik; Sami Dogan
Journal:  J Clin Med Res       Date:  2014-07-28

3.  Hyperplastic thymus with increased angiogenesis is correlated with elevated serum thyroglobulin level in differentiated thyroid cancer patients with TENIS syndrome.

Authors:  Guangjian Zhang; Rui Gao; Yuanbo Wang; Yan Liu; Juan Li; Xi Jia; Yiqian Liang; Aimin Yang
Journal:  Oncotarget       Date:  2017-12-15

4.  Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up.

Authors:  Filiz Hatipoğlu; İnanç Karapolat; Özgür Ömür; Ayşegül Akgün; Ahmet Yanarateş; Kamil Kumanlıoğlu
Journal:  Mol Imaging Radionucl Ther       Date:  2016-06-05

5.  Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assays.

Authors:  Martina Broecker-Preuss; Irina Mehnert; Elena Gilman; Ken Herrmann; Manuel Weber; Rainer Görges
Journal:  Pract Lab Med       Date:  2021-07-27

6.  Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?

Authors:  Hilda Wong; Kai P Wong; Thomas Yau; Vikki Tang; Roland Leung; Joanne Chiu; Brian Hung-Hin Lang
Journal:  Ann Surg Oncol       Date:  2012-05-11       Impact factor: 5.344

7.  Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [18F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma.

Authors:  Domenico Albano; Mark Tulchinsky; Francesco Dondi; Angelica Mazzoletti; Davide Lombardi; Francesco Bertagna; Raffaele Giubbini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08-13       Impact factor: 9.236

8.  The role of Tg kinetics in predicting 2-[18F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan.

Authors:  Domenico Albano; Mark Tulchinsky; Francesco Dondi; Angelica Mazzoletti; Francesco Bertagna; Raffaele Giubbini
Journal:  Endocrine       Date:  2021-05-20       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.